Hiroyuki Kodama

2PUBLICATIONS
20CO-AUTHORS
Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 19, 2026
Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.

|May 08, 2025
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS).

Hiroyuki Kodama, Yukiya Narita, Michio Nakamura

Pageof 1

Frequent Collaborators

2 joint publications

Yukiya Narita

1 joint publications

Michio Nakamura

1 joint publications

Masanobu Takahashi

1 joint publications

Takuro Mizukami